University of Zurich

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 1833-04-29

Employees: 5K

Market Cap: -

Website: http://www.uzh.ch

Clinical Trials

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention

Phase 3

Recruiting

Conditions: Stroke, Ischemic

Interventions: Drug: Aspirin
Drug: Dabigatran
Drug: Apixaban
Drug: Clopidogrel
Drug: Edoxaban

First Posted Date: 2019-05-23

Last Posted Date: 2023-08-16

Lead Sponsor: University of Zurich

Target Recruit Count: 620

Registration Number: NCT03961334

Locations: 🇬🇷
Attikon University Hospital, Athens, Greece
🇪🇸
Hospital Universitario Virgen Macarena, Sevilla, Spain
🇨🇭
University Hospital of Basel, Basel, Switzerland

and more 11 locations

Early Signs of Altitude Illness in Patients With COPD

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Diagnostic Test: Structured self-monitoring during an altitude ascent and stay at high altitude

First Posted Date: 2019-05-21

Last Posted Date: 2022-11-29

Lead Sponsor: University of Zurich

Target Recruit Count: 153

Registration Number: NCT03957759

Locations: 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effects of HFOT on Exercise Performance in Patients With COPD. A Randomized, Controlled Trial.

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Combination Product: High-flow oxygen therapy (HFOT)
Combination Product: Low-flow oxygen therapy (LFOT)

First Posted Date: 2019-05-20

Last Posted Date: 2020-02-06

Lead Sponsor: University of Zurich

Target Recruit Count: 79

Registration Number: NCT03955770

Locations: 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Optimizing Psychotherapy for Anxiety Disorders

Not Applicable

Conditions: Anxiety Disorders

Interventions: Behavioral: Unified Treatment Protocol

First Posted Date: 2019-05-10

Last Posted Date: 2019-05-10

Lead Sponsor: University of Zurich

Target Recruit Count: 200

Registration Number: NCT03945617

Locations: 🇨🇭
University of Zurich, Zürich, Switzerland

Efficacy of Equine Assisted Therapy on Negative Symptoms in Patients With Schizophrenia

Not Applicable

Conditions: Animal Assisted Therapy

Interventions: Behavioral: equine assisted therapy
Behavioral: activating control phase

First Posted Date: 2019-05-02

Last Posted Date: 2019-12-06

Lead Sponsor: University of Zurich

Target Recruit Count: 16

Registration Number: NCT03935243

Locations: 🇨🇭
Psychiatrische Universitätsklinik Zürich, Zürich, Switzerland

NISCI - Nogo Inhibition in Spinal Cord Injury

Phase 2

Completed

Conditions: Spinal Cord Injury, Acute

Interventions: Drug: Placebos
Drug: NG-101

First Posted Date: 2019-05-02

Last Posted Date: 2023-04-04

Lead Sponsor: University of Zurich

Target Recruit Count: 129

Registration Number: NCT03935321

Locations: 🇩🇪
Klinik für Querschnittgelähmte, Klinikum Bayreuth, Bayreuth, Germany
🇨🇿
Spinal Cord Unit, University Hospital Motol, Praha, Czechia
🇩🇪
Abteilung für Rückenmarkverletzte, BG Universitätsklinikum Bergmannsheil gGmbH, Bochum, Germany

and more 10 locations

Pembrolizumab for Newly Diagnosed Glioblastoma

Phase 2

Active, not recruiting

Conditions: Newly Diagnosed Glioblastoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2019-04-02

Last Posted Date: 2024-05-08

Lead Sponsor: University of Zurich

Target Recruit Count: 56

Registration Number: NCT03899857

Locations: 🇨🇭
University Hospital Zurich, Zürich, Switzerland
🇨🇭
University Hospital Bern / Inselspital, Bern, Switzerland
🇨🇭
University Hospital Lausanne, CHUV, Lausanne, Switzerland

ICCAC-ToNF & Tinnitus

Not Applicable

Completed

Conditions: Tinnitus, Subjective

Interventions: Other: tomographic EEG Neurofeedback Training

First Posted Date: 2019-03-29

Last Posted Date: 2021-10-13

Lead Sponsor: University of Zurich

Target Recruit Count: 36

Registration Number: NCT03895047

Locations: 🇨🇭
University Hospital Zurich, Division of Otorhinolaryngology ORL, Zurich, ZH, Switzerland

The SwissPrEPared Study

Recruiting

Conditions: HIV Preexposure Prophylaxis

First Posted Date: 2019-03-28

Last Posted Date: 2023-04-06

Lead Sponsor: University of Zurich

Target Recruit Count: 3000

Registration Number: NCT03893188

Locations: 🇨🇭
Kantonsspital Olten, Olten, Solothurn, Switzerland
🇨🇭
Kantonsspital Graubünden, Chur, Graubünden, Switzerland
🇨🇭
Praxis Emmanuelle Boffi, Geneva, Switzerland

and more 38 locations

Repetitive Transorbital Alternating Current Stimulation in Acute Autoimmune Optic Neuritis

Not Applicable

Terminated

Conditions: Acute Autoimmune Inflammatory Optic Neuritis

Interventions: Device: active-rtACS treatment
Device: sham-rtACS treatment

First Posted Date: 2019-03-05

Last Posted Date: 2021-03-30

Lead Sponsor: University of Zurich

Target Recruit Count: 2

Registration Number: NCT03862313

Locations: 🇨🇭
Department of Neurology and Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy